Infringement of dermal filler patents

Vaccine with syringe

In a patent infringement litigation between rival manufacturers of dermal fillers, CRA was asked to opine on damages suffered by plaintiffs. In an expert report, CRA analyzed lost profits and reasonable royalty damages, examining the market and buying patterns for dermal fillers. In considering the hypothetical negotiation, CRA examined features linked to the patents at issue and other features not subject to the negotiation.

Meet our team